Oxytocin

Oxytocin is a neuropeptide hormone produced naturally in the hypothalamus and released by the posterior pituitary gland. Often called the "bonding hormone" or "love hormone," oxytocin plays a central role in social behavior, emotional bonding, trust, and a wide range of physiological processes. In research contexts, synthetic oxytocin (10mg vials) is used to investigate its mechanisms of action across neuroscience, endocrinology, reproductive biology, and behavioral science.

Chemical Profile

Oxytocin is a nine-amino acid cyclic peptide (nonapeptide) with the sequence Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly, linked by a disulfide bond between positions 1 and 6. Its molecular formula is C₄₃H₆₆N₁₂O₁₂S₂, with a molecular weight of approximately 1007.19 g/mol. The compound has high structural similarity to vasopressin (AVP), with only two amino acid differences, which explains the partial cross-reactivity between the two peptides at their respective receptors.

**Identifiers:** - CAS Number: 50-56-6 - Molecular Formula: C₄₃H₆₆N₁₂O₁₂S₂ - Molecular Weight: ~1007.19 g/mol - Sequence: H-Cys¹-Tyr²-Ile³-Gln⁴-Asn⁵-Cys⁶-Pro⁷-Leu⁸-Gly⁹-NH₂ (with S-S bridge 1-6) - Research grade purity: ≥99% - Form: Lyophilized powder, 10mg per vial

Mechanism of Action

Oxytocin exerts its biological effects primarily through the oxytocin receptor (OXTR), a G-protein-coupled receptor (GPCR) coupled to Gq proteins. Upon binding:

1. **Phospholipase C activation** → IP₃ and DAG production → intracellular calcium release 2. **Downstream signaling** → MAPK/ERK pathway activation, modulation of cAMP, and regulation of gene expression 3. **Receptor distribution** is widespread: uterine smooth muscle, mammary glands, brain regions (amygdala, hypothalamus, nucleus accumbens, prefrontal cortex), cardiovascular tissues, and the gut

In the central nervous system, oxytocin acts as a neuromodulator, influencing serotonin, dopamine, and GABA systems. It reduces amygdala reactivity to social threats and enhances activity in reward circuits, forming the neurobiological basis for its pro-social effects.

In peripheral tissues, oxytocin regulates: - **Uterine contractions** during parturition and lactation (milk ejection reflex) - **Cardiovascular function** — cardioprotective effects, regulation of blood pressure - **Metabolic activity** — adipogenesis inhibition, glucose uptake modulation - **Immune modulation** — anti-inflammatory cytokine regulation

Research Areas

### Social Behavior and Neuroscience Oxytocin's role in social bonding is extensively studied. Intranasal administration in human subjects has been shown to increase trust, reduce social anxiety, enhance face recognition, and improve the ability to infer emotions. Research using animal models (rodents, voles, primates) has mapped the neural circuits through which OXTR signaling mediates pair bonding, maternal behavior, and group affiliation.

Key findings from published research: - Intraventricular or intranasal oxytocin increases prosocial approach behaviors in social defeat models - OXTR knockout mice show deficits in social recognition and maternal care - Oxytocin release in the nucleus accumbens is critical for social reward - Amygdala OXTR signaling reduces fear responses to social cues

### Autism Spectrum Disorder (ASD) Among the most active translational research areas involving oxytocin. Early studies showed that individuals with ASD have atypical oxytocin signaling, including lower plasma oxytocin and altered OXTR gene methylation. Clinical trials have investigated intranasal oxytocin to improve social cognition and reduce core ASD symptoms. Results have been mixed but continue to motivate mechanistic research into the oxytocin system in neurodevelopmental conditions.

### Anxiety and Stress Oxytocin has anxiolytic properties, largely mediated via the hypothalamic-pituitary-adrenal (HPA) axis. It reduces cortisol secretion in response to social stressors and attenuates the stress response in animal models. Research contexts include PTSD, generalized anxiety disorder, and stress-induced immune dysregulation. The interaction between oxytocin and corticotropin-releasing factor (CRF) systems is a primary focus.

### Reproductive Biology Oxytocin's role in parturition and lactation has been studied since the early 20th century. In research settings, oxytocin analogs and receptor agonists/antagonists help elucidate the timing and regulation of uterine contractility. Atosiban (an OXTR antagonist) was developed as a tocolytic agent, underscoring the translational importance of this research. Studies also examine oxytocin's role in sperm motility, sexual arousal, and orgasm.

### Cardiovascular Research Cardiac OXTR expression has been confirmed in cardiomyocytes. Research has shown that oxytocin promotes natriuresis, vasodilation, and reduces heart rate. Pre-clinical studies in myocardial infarction models suggest oxytocin may have cardioprotective effects, including attenuation of ischemia-reperfusion injury and reduction of infarct size. The cardiovascular applications represent a growing frontier in oxytocin research.

### Metabolic Research Oxytocin neurons in the paraventricular nucleus project to areas governing appetite and energy balance. Animal studies show that central OXTR activation reduces food intake, particularly of carbohydrates. Oxytocin also appears to interact with leptin signaling and may modulate adipocyte differentiation. This has led to interest in studying oxytocin as part of multi-peptide metabolic research protocols, particularly alongside GLP-1 receptor agonists.

### Pain and Inflammation Spinal cord OXTR expression has been demonstrated. Intrathecal oxytocin produces analgesia in rodent pain models. In inflammatory contexts, oxytocin modulates macrophage polarization toward anti-inflammatory phenotypes and reduces pro-inflammatory cytokine expression (TNF-α, IL-6, IL-1β). Gastrointestinal inflammation models have shown oxytocin may have protective effects in colitis.

Research Administration (Preclinical Models)

Standard approaches in published preclinical research include:

| Route | Use Case | Notes | |-------|----------|-------| | Subcutaneous (SC) | Systemic delivery | Standard for peripheral effects | | Intracerebroventricular (ICV) | Central nervous system targeting | Requires stereotaxic surgery | | Intranasal | CNS access with lower invasiveness | Variable brain uptake in animal models | | Intraperitoneal (IP) | Behavioral studies | Rapid absorption |

Reconstitution is typically performed with sterile bacteriostatic water or sterile saline. Peptide stability is maintained when stored lyophilized at -20°C; reconstituted solutions are stable at 4°C for short-term use.

Oxytocin has a short plasma half-life (approximately 1–6 minutes IV due to rapid degradation by oxytocinase/leucyl-aminopeptidase). Research protocols often use sustained-release formulations, analogs with enhanced stability, or continuous infusion paradigms to maintain target tissue exposure.

Regulatory and Safety Context

This product is supplied **for research use only (RUO)**. It is not approved for human administration, diagnostic use, or veterinary therapeutic use outside of licensed clinical or veterinary settings. Researchers working with oxytocin should adhere to all applicable institutional review board (IRB), IACUC, and regulatory requirements for their jurisdiction.

Oxytocin is not a controlled substance in most jurisdictions, but clinical formulations (e.g., Pitocin) are prescription-only drugs regulated by the FDA and equivalent agencies. Research-grade peptide supply chains are distinct from pharmaceutical manufacturing pathways.

Product Specifications

| Parameter | Value | |-----------|-------| | Peptide | Oxytocin | | Quantity | 10mg per vial | | Form | Lyophilized powder | | Purity | ≥99% (HPLC) | | Certificate of Analysis | Available upon request | | Storage | -20°C (lyophilized); 4°C (reconstituted, short-term) | | Reconstitution | Sterile bacteriostatic water or 0.9% NaCl | | Intended Use | Research use only |

Comparative Context: Oxytocin vs. Vasopressin

Because oxytocin and vasopressin (AVP) share substantial structural similarity, researchers investigating social or stress-related behaviors often study both peptides in parallel. Key distinctions:

- **Oxytocin** primarily acts via OXTR; primary effects are social bonding, uterine contraction, milk ejection, anxiolysis - **Vasopressin** primarily acts via V1a, V1b, V2 receptors; primary effects are antidiuretic, vasopressor, aggression-related social behavior

Both peptides can bind each other's receptors at high concentrations, making receptor subtype-selective pharmacological tools important for clean mechanistic studies. Research-grade oxytocin at defined purity is critical for ensuring that observations in social behavior models are attributable to OXTR, not off-target vasopressin receptor activation.

Key References

Research on synthetic oxytocin draws from decades of foundational work and a growing clinical literature. Representative research themes include: - Insel TR (2010). "The Challenge of Translation in Social Neuroscience: A Review of Oxytocin, Vasopressin, and Affiliative Behavior." *Neuron* - Carter CS (2014). "Oxytocin pathways and the evolution of human behavior." *Annual Review of Psychology* - Bartz JA et al. (2011). "Social effects of oxytocin in humans: context and person matter." *Trends in Cognitive Sciences* - MacDonald K, MacDonald TM (2010). "The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans." *Harvard Review of Psychiatry*

*This product is intended for research use only. Not for human or veterinary therapeutic use. Researchers must comply with all applicable institutional and regulatory requirements.*